Sesen Bio Inc. [NASDAQ: SESN] jumped around 0.03 points on Thursday, while shares priced at $1.06 at the close of the session, up 2.91%. The company report on November 2, 2020 that Sesen Bio to Host Conference Call to Review Third Quarter Financial Results and Provide an Update on Positive Progress Towards Demonstration of Analytical Comparability.
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, announced that Company management will host a conference call on Monday, November 9, 2020 at 8:00 a.m. ET to review operating results for the third quarter ended September 30, 2020. The Company will also provide an update on the progress of studies related to assessing analytical comparability between clinical batches of Vicineum and commercial material, a key component of Module 3 required to finalize the BLA submission.
To participate in the conference call, please dial (844) 831-3025 (domestic) or (315) 625-6887 (international) and refer to conference ID 9360749. The webcast can be accessed in the Investor Relations section of the company’s website at www.sesenbio.com. The replay of the webcast will be available in the investor section of the company’s website at www.sesenbio.com for 60 days following the call.
Sesen Bio Inc. stock is now 1.92% up from its year-to-date (YTD) trading value. SESN Stock saw the intraday high of $1.07 and lowest of $1.02 per share. The company’s 52-week high price is 1.54, which means current price is +186.49% above from all time high which was touched on 09/30/20.
Compared to the average trading volume of 2.20M shares, SESN reached a trading volume of 1323471 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sesen Bio Inc. [SESN]?
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 11, 2019.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.09
How has SESN stock performed recently?
Sesen Bio Inc. [SESN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.85. With this latest performance, SESN shares dropped by -21.48% in over the last four-week period, additionally plugging by 31.29% over the last 6 months – not to mention a drop of -7.83% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 43.48, with the RSI for the last a single of trading hit 40.40, and the three-weeks RSI is set at 44.16 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 1.1559, while it was recorded at 1.0280 for the last single week of trading, and 0.8647 for the last 200 days.
Sesen Bio Inc. [SESN]: Deeper insight into the fundamentals
Return on Total Capital for SESN is now -421.21, given the latest momentum, and Return on Invested Capital for the company is -1,228.08. Return on Equity for this stock declined to -1,228.08, with Return on Assets sitting at -95.16.
Reflecting on the efficiency of the workforce at the company, Sesen Bio Inc. [SESN] managed to generate an average of -$4,300,000 per employee.Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.40 and a Current Ratio set at 6.40.
Earnings analysis for Sesen Bio Inc. [SESN]
With the latest financial reports released by the company, Sesen Bio Inc. posted -0.13/share EPS, while the average EPS was predicted by analysts to be reported at -0.11/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -18.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SESN.
Insider trade positions for Sesen Bio Inc. [SESN]
There are presently around $20 million, or 16.10% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: TRV GP, LLC with ownership of 4,841,591, which is approximately 0% of the company’s market cap and around 0.07% of the total institutional ownership; VANGUARD GROUP INC, holding 4,001,225 shares of the stock with an approximate value of $4.24 million in SESN stocks shares; and EVERSEPT PARTNERS, LP, currently with $2.12 million in SESN stock with ownership of nearly 53.846% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 24 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 2,889,698 shares. Additionally, 11 investors decreased positions by around 1,155,369 shares, while 10 investors held positions by with 14,951,133 shares. The mentioned changes placed institutional holdings at 18,996,200 shares, according to the latest SEC report filing. SESN stock had 8 new institutional investments in for a total of 509,861 shares, while 3 institutional investors sold positions of 36,899 shares during the same period.